Survival Status and Predictors of Mortality among Multidrug-Resistant Tuberculosis Patients in Saint Peter's Specialized Hospital, Addis Ababa, Ethiopia.
Mikyas Arega MulunehAbayneh Birlie ZeruBehailu Tariku DersehAbebaw Molla KebedePublished in: The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale (2021)
MDR-TB patients' survival rate was high in St Peter's Specialized Hospital. MDR-TB patients with anemia, HIV coinfection, and clinical complications had higher risk of mortality. So, prevention and controlling of anemia, HIV/AIDS, and clinical complications will reduce the mortality of MDR-TB patients.
Keyphrases
- multidrug resistant
- end stage renal disease
- hiv aids
- chronic kidney disease
- ejection fraction
- newly diagnosed
- mycobacterium tuberculosis
- healthcare
- prognostic factors
- peritoneal dialysis
- risk factors
- antiretroviral therapy
- palliative care
- type diabetes
- escherichia coli
- cardiovascular disease
- drug resistant
- adverse drug
- south africa